Found 312 results for cardinal-health

Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies.

Crystal tombstone marking the initial public offering of Japanese medical database company JMDC.

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

Custom deal toy marking a follow-on stock offering by Translate Bio. The biotech firm specializes in the treatment of diseases caused by protein or gene dysfunction.

Custom deal tombstone celebrating the initial public offering by Rameda, Pharmaceuticals, a Cairo-based generic drug firm.

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors.

Custom deal toy celebrating the initial public offering by South Korean firm SK Biopharmaceuticals. The listing on Seoul’s main stock exchange was the largest in South Korea since 2017. .

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.